Academy of Managed Care Pharmacy (AMCP) - Comment

Document ID: FDA-2011-N-0326-0026
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: December 21 2011, at 12:00 AM Eastern Standard Time
Date Posted: January 11 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: December 7 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: January 6 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80f87518
View Document:

This is comment on Notice

Recommendations for User Fee Programs: Biosimilar and Interchangeable Biological Product Applications for Fiscal Years 2013 Through 2017; Meeting

View Comment

The Academy of Managed Care Pharmacy (AMCP) is pleased to provide comments to the Food and Drug Administration (FDA) on Options for a User Fee Program for Biosimilar and Interchangeable Biological Product Applications for Fiscal Years 2013 through 2017. ***Please see additional comments attached***

Attachments:

Academy of Managed Care Pharmacy (AMCP) - Comment FDA biosimilar user fee program 1.2012

Title:
Academy of Managed Care Pharmacy (AMCP) - Comment FDA biosimilar user fee program 1.2012

View Attachment:

Related Comments

View All

Total: 12

Academy of Managed Care Pharmacy (AMCP) - Comment
Public Submission Posted: 01/11/2012 ID: FDA-2011-N-0326-0026